{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:51:57Z","timestamp":1780354317646,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The surge of methamphetamine use has been a complicating factor compounding the steeply increasing number of drug overdose deaths in the U.S. Infection from blood-borne viruses including hepatitis B virus (HBV), hepatitis C virus (HCV) and HIV, related to methamphetamine use continue to grow. This study aims to examine the risk factors associated with HBV, HCV and HIV among people who used methamphetamine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>People who ever used methamphetamine were identified from five National Health and Nutrition Examination Survey (NHANES) cohorts, 2007 to 2016. The outcome was either positive or negative for blood-borne viruses as identified from laboratory tests. Weighted statistics for the combined ten years of data were calculated by multiplying the weighted variable for laboratory measurements by 0.2. We examined the association of sexual activities (sexual partners, sexual identity), drug use behaviors (poly-drug use, injection drug use, frequency of drug use, age started using methamphetamine), demographics, and socio-economic status with blood-borne viruses using bivariate and multivariable logistic regression models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 1132 participants representing approximately 11,996,319 persons who ever used methamphetamine in the U.S. Blood-borne viruses\u2019 positive rate was 13.0 per 100,000. Multivariable logistic regression analyses showed significant associations of blood-borne infections with age 40\u201349\u2009years (vs. age 20\u201329\u2009years, adjusted odds ratio 4.77, 95% CI 1.11\u201320.55), age 50\u201359\u2009years (vs. age 20\u201329\u2009years, 10.25, 2.40\u201343.82), living within poverty index 1\u20131.9 (vs. poverty index &gt;\u2009=\u20092, 2.55; 1.19\u20135.49), living below the poverty threshold (vs. poverty index &gt;\u2009=\u20092, 2.55; 1.11\u20135.86), having lower than high school education (vs. equal or higher than high school education, 3.13; 1.51\u20136.46), sexual identity as other than heterosexual (vs. heterosexual, 5.60; 1.72\u201318.28), using methamphetamine and heroin and cocaine (vs. using methamphetamine alone, 4.24; 1.06\u201316.92), injection drug use (vs. no injection drug use, 3.15; 1.61\u20136.16), and started using methamphetamine at age above 25 (vs. started using methamphetamine at age between 10 and 17, 2.09; 1.01\u20134.35).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among people who use methamphetamine, those who use polysubstance, or who inject substances, are in urgent need for vaccination and interventions to avoid further harm from blood borne infections.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05464-y","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T09:03:00Z","timestamp":1602234180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Risk factors associated with infection of blood-borne virus among people who used methamphetamine"],"prefix":"10.1186","volume":"20","author":[{"given":"Yilin","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5943-0748","authenticated-orcid":false,"given":"Zheng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"issue":"17","key":"5464_CR1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.15585\/mmwr.mm6817a3","volume":"68","author":"M Kariisa","year":"2019","unstructured":"Kariisa M, Scholl L, Wilson N, et al. Drug overdose deaths involving cocaine and psychostimulants with abuse potential \u2013 United States, 2003-2017. Morb Mortal Wkly Rep. 2019;68(17):388\u201395 https:\/\/doi.org\/10.15585\/mmwr.mm6817a3.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"5152","key":"5464_CR2","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.15585\/mmwr.mm675152e1","volume":"67","author":"L Scholl","year":"2019","unstructured":"Scholl L, Seth P, Kariisa M, et al. Drug and opioid-involved overdose deaths\u2014United States, 2013\u20132017. Morb Mortal Wkly Rep. 2019;67(5152):1419\u201327. https:\/\/doi.org\/10.15585\/mmwr.mm675152e1.","journal-title":"Morb Mortal Wkly Rep"},{"key":"5464_CR3","unstructured":"National Center for Health Statistics (NCHS). Provisional Drug Overdose Death Counts. 2019; Available from: https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm#data-tables. Accessed 22 Dec 2019."},{"issue":"10209","key":"5464_CR4","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/S0140-6736(19)32230-5","volume":"394","author":"M Farrell","year":"2019","unstructured":"Farrell M, Martin NK, Stockings E, et al. Responding to global stimulant use: challenges and opportunities. Lancet. 2019;394(10209):1652\u201367. https:\/\/doi.org\/10.1016\/S0140-6736(19)32230-5.","journal-title":"Lancet."},{"issue":"6","key":"5464_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.15585\/mmwr.mm6806a4","volume":"68","author":"SE Kidd","year":"2019","unstructured":"Kidd SE, Grey JA, Torrone EA, et al. Increased methamphetamine, injection drug, and heroin use among women and heterosexual men with primary and secondary syphilis\u2014United States, 2013\u20132017. Morb Mortal Wkly Rep. 2019;68(6):144\u20138. https:\/\/doi.org\/10.15585\/mmwr.mm6806a4.","journal-title":"Morb Mortal Wkly Rep"},{"key":"5464_CR6","unstructured":"Centers for Disease Control and Prevention (CDC). Infectious Diseases, opioids and injection drug use. 2019; Available from: https:\/\/www.cdc.gov\/pwid\/opioid-use.html. Accessed 22 Dec 2019."},{"key":"5464_CR7","unstructured":"National Institute for Occupational Safety and Health (NIOSH). Bloodborne infectious diseases: HIV\/AIDS, Hepatitis B, Hepatitis C. 2019; Available from: https:\/\/www.cdc.gov\/niosh\/topics\/bbp\/default.html. Accessed 23 Dec 2019."},{"issue":"5","key":"5464_CR8","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/j.1360-0443.2006.01407.x","volume":"101","author":"TM Vogt","year":"2006","unstructured":"Vogt TM, Perz JF, Van Houten Jr CK, et al. An outbreak of hepatitis B virus infection among methamphetamine injectors: the role of sharing injection drug equipment. Addiction. 2006;101(5):726\u201330. https:\/\/doi.org\/10.1111\/j.1360-0443.2006.01407.x.","journal-title":"Addiction."},{"issue":"4","key":"5464_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s11904-005-0016-4","volume":"2","author":"G Colfax","year":"2005","unstructured":"Colfax G, Shoptaw S. The methamphetamine epidemic: implications for HIV prevention and treatment. Curr HIV\/AIDS Rep. 2005;2(4):194\u20139. https:\/\/doi.org\/10.1007\/s11904-005-0016-4.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"3","key":"5464_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa1515195","volume":"375","author":"PJ Peters","year":"2016","unstructured":"Peters PJ, Pontones P, Hoover KW, et al. HIV infection linked to injection use of oxymorphone in Indiana, 2014\u20132015. N Engl J Med. 2016;375(3):229\u201339. https:\/\/doi.org\/10.1056\/NEJMoa1515195.","journal-title":"N Engl J Med"},{"issue":"2","key":"5464_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3109\/00952990.2015.1114625","volume":"42","author":"JL Montoya","year":"2016","unstructured":"Montoya JL, Cattie J, Morgan E, et al. The impact of age, HIV serostatus and seroconversion on methamphetamine use. Am J Drug Alcohol Abuse. 2016;42(2):168\u201377. https:\/\/doi.org\/10.3109\/00952990.2015.1114625.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2","key":"5464_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/infdis\/jiz445","volume":"221","author":"SR Tressler","year":"2019","unstructured":"Tressler SR, Kushner T, Bhandari R. Factors associated with hepatitis B exposure among people who report using methamphetamine: NHANES 2009-2016. Int J Infect Dis. 2019;221(2):243\u201350. https:\/\/doi.org\/10.1093\/infdis\/jiz445.","journal-title":"Int J Infect Dis"},{"issue":"3","key":"5464_CR13","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jadohealth.2008.08.007","volume":"44","author":"CL Miller","year":"2009","unstructured":"Miller CL, Kerr T, Fischer B, et al. Methamphetamine injection independently predicts hepatitis C infection among street-involved youth in a Canadian setting. J Adolesc Health. 2009;44(3):302\u20134. https:\/\/doi.org\/10.1016\/j.jadohealth.2008.08.007.","journal-title":"J Adolesc Health"},{"key":"5464_CR14","unstructured":"National Institute on Drug Abuse (NIDA). Methamphetamine. 2019; Available from: https:\/\/www.drugabuse.gov\/publications\/drugfacts\/methamphetamine. Accessed 22 Dec 2019."},{"issue":"3","key":"5464_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.14219\/jada.archive.2010.0165","volume":"141","author":"V Shetty","year":"2010","unstructured":"Shetty V, Mooney LJ, Zigler CM, et al. The relationship between methamphetamine use and increased dental disease. J Am Dent Assoc. 2010;141(3):307\u201318. https:\/\/doi.org\/10.14219\/jada.archive.2010.0165.","journal-title":"J Am Dent Assoc"},{"key":"5464_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.drugalcdep.2018.08.029","volume":"193","author":"MS Ellis","year":"2018","unstructured":"Ellis MS, Kasper ZA, Cicero TJ. Twin epidemics: the surging rise of methamphetamine use in chronic opioid users. Drug Alcohol Depend. 2018;193:14\u201320. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.08.029.","journal-title":"Drug Alcohol Depend"},{"key":"5464_CR17","doi-asserted-by":"crossref","unstructured":"Hedegaard H, Mini\u00f1o AM, Warner M. Drug overdose deaths in the United States, 1999\u20132018. NCHS Data Brief, no 356. 2020; Available from: https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db356.htm. Accessed 22 July 2020.","DOI":"10.15620\/cdc:112340"},{"issue":"34","key":"5464_CR18","doi-asserted-by":"publisher","first-page":"737","DOI":"10.15585\/mmwr.mm6834a2","volume":"68","author":"RM Gladden","year":"2019","unstructured":"Gladden RM, O'Donnell J, Mattson CL, et al. Changes in opioid-involved overdose deaths by opioid type and presence of benzodiazepines, cocaine, and methamphetamine - 25 states, July-December 2017 to January-June 2018. Morb Mortal Wkly Rep. 2019;68(34):737\u201344. https:\/\/doi.org\/10.15585\/mmwr.mm6834a2.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"4","key":"5464_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/YCO.0000000000000069","volume":"27","author":"JP Connor","year":"2014","unstructured":"Connor JP, Gullo MJ, White J, et al. Current opinion in psychiatry: polysubstance use: diagnostic challenges, patterns of use and health. Curr Opin Psychiatry. 2014;27(4):269\u201375. https:\/\/doi.org\/10.1097\/YCO.0000000000000069.","journal-title":"Curr Opin Psychiatry"},{"issue":"2","key":"5464_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/add.14812","volume":"115","author":"CM Jones","year":"2019","unstructured":"Jones CM, Underwood N, Compton WM. Increases in methamphetamine use among heroin treatment admissions in the United States, 2008\u201317. Addiction. 2019;115(2):347\u201353. https:\/\/doi.org\/10.1111\/add.14812.","journal-title":"Addiction."},{"issue":"3","key":"5464_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/QAI.0000000000001098","volume":"73","author":"M Van Handel","year":"2016","unstructured":"Van Handel M, Rose CE, Hallisey EJ, et al. County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States. J Acquir Immune Defic Syndr. 2016;73(3):323\u201331. https:\/\/doi.org\/10.1097\/QAI.0000000000001098.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"5464_CR22","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2105\/AJPH.92.3.385","volume":"92","author":"CS Murrill","year":"2002","unstructured":"Murrill CS, Weeks H, Castrucci BC, et al. Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health. 2002;92:385\u20137. https:\/\/doi.org\/10.2105\/AJPH.92.3.385.","journal-title":"Am J Public Health"},{"key":"5464_CR23","doi-asserted-by":"publisher","unstructured":"Shing JZ, Ly KN, Xing J, et al. Prevalence of hepatitis B virus infection among US adults aged 20\u201359 years with a history of injection drug use: National Health and Nutrition Examination Survey, 2001\u20132016. Clin Infect Dis. 2019:ciz669. https:\/\/doi.org\/10.1093\/cid\/ciz669.","DOI":"10.1093\/cid\/ciz669"},{"issue":"11","key":"5464_CR24","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/cid\/cix1079","volume":"66","author":"M Rickles","year":"2017","unstructured":"Rickles M, Rebeiro PF, Sizemore L, et al. Tennessee\u2019s in-state vulnerability assessment for a \u2018rapid dissemination of HIV or HCV infection\u2019 event utilizing data about the opioid epidemic. Clin Infect Dis. 2017;66(11):1722\u201332. https:\/\/doi.org\/10.1093\/cid\/cix1079.","journal-title":"Clin Infect Dis"},{"key":"5464_CR25","unstructured":"National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey. 2019; Available from: www.cdc.gov\/nchs\/nhanes\/index.htm. Accessed 23 Dec 2019."},{"key":"5464_CR26","doi-asserted-by":"publisher","DOI":"10.1017\/S095026881900133X","volume":"147","author":"L Smith","year":"2019","unstructured":"Smith L, Cao C, Zong X, et al. Syndemic effects of HIV risk behaviours: results from the NHANES study. Epidemiol Infect. 2019;147:e241. https:\/\/doi.org\/10.1017\/S095026881900133X.","journal-title":"Epidemiol Infect"},{"issue":"9","key":"5464_CR27","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1093\/cid\/ciz537","volume":"70","author":"H King","year":"2020","unstructured":"King H, Xing J, Dean HD, et al. Trends in prevalence of protective levels of hepatitis B surface antibody among adults aged 18\u201349 years with risk factors for hepatitis B virus infection\u2014United States, 2003\u20132014. Clin Infect Dis. 2020;70(9):1907\u201315. https:\/\/doi.org\/10.1093\/cid\/ciz537.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"5464_CR28","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/cld.728","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok AS, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560\u201399. https:\/\/doi.org\/10.1002\/cld.728.","journal-title":"Hepatology."},{"key":"5464_CR29","unstructured":"Getchell JP, Wroblewski KE, DeMaria Jr A, et al. Testing for HCV infection: an update of guidance for clinicians and laboratorians. Morb Mortal Wkly Rep 2013;62(18):362\u2013365. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4605020\/. Accessed 22 July 2020."},{"key":"5464_CR30","unstructured":"Centers for Disease Control and Prevention (CDC). 2018 quick reference guide: recommended laboratory HIV testing algorithm for serum or plasma specimens. 2018; Available from: https:\/\/stacks.cdc.gov\/view\/cdc\/50872. Accessed 22 July 2020."},{"issue":"5","key":"5464_CR31","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1037\/neu0000552","volume":"33","author":"C Basterfield","year":"2019","unstructured":"Basterfield C, Hester R, Bowden SC. A meta-analysis of the relationship between abstinence and neuropsychological functioning in methamphetamine use disorder. Neuropsychology. 2019;33(5):739\u201353. https:\/\/doi.org\/10.1037\/neu0000552.","journal-title":"Neuropsychology."},{"issue":"5","key":"5464_CR32","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/QAI.0000000000000888","volume":"71","author":"M Hoenigl","year":"2016","unstructured":"Hoenigl M, Chaillon A, Moore DJ, et al. Clear links between starting methamphetamine and increasing sexual risk behavior: a cohort study among men who have sex with men. J Acquir Immune Defic Syndr. 2016;71(5):551\u20137. https:\/\/doi.org\/10.1097\/QAI.0000000000000888.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"5464_CR33","unstructured":"National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey. 2019; Available from: https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/tutorials\/module3.aspx.Accessed 02 Sept 2020."},{"issue":"4","key":"5464_CR34","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/add.12846","volume":"110","author":"I Tavitian-Exley","year":"2015","unstructured":"Tavitian-Exley I, Vickerman P, Bastos FI, et al. Influence of different drugs on HIV risk in people who inject: systematic review and meta-analysis. Addiction. 2015;110(4):572\u201384. https:\/\/doi.org\/10.1111\/add.12846.","journal-title":"Addiction."},{"issue":"1","key":"5464_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2006.11.014","volume":"89","author":"R Scheinmann","year":"2007","unstructured":"Scheinmann R, Hagan H, Lelutiu-Weinberger C, et al. Non-injection drug use and hepatitis C virus: a systematic review. Drug Alcohol Depend. 2007;89(1):1\u201312. https:\/\/doi.org\/10.1016\/j.drugalcdep.2006.11.014.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"5464_CR36","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.drugalcdep.2013.03.004","volume":"132","author":"RC Trenz","year":"2013","unstructured":"Trenz RC, Scherer M, Duncan A, et al. Latent class analysis of polysubstance use, sexual risk behaviors, and infectious disease among south African drug users. Drug Alcohol Depend. 2013;132(3):441\u20138. https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.03.004.","journal-title":"Drug Alcohol Depend"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05464-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05464-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05464-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T15:07:25Z","timestamp":1669129645000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05464-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5464"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05464-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.22230\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.22230\/v5","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.22230\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.22230\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.22230\/v3","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,9]]},"assertion":[{"value":"27 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study is a secondary analysis of existing National Health and Nutrition Examination Survey (NHANES) public data available at:\n                      \n                      The National Center for Health Statistics (NCHS) Institutional Review Board (IRB) or Research Ethics Review Board (ERB) approved the survey protocols, Protocol #2005\u201306, #2011\u201317, and their continuations for the data used in this study. All adult participants gave written informed consent for both the in-home interview and the health exam. Additional information including protocol numbers are available at:\n                      \n                      (accessed on September 28, 2020).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No conflict declared.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"742"}}